2024 Q2 Form 10-Q Financial Statement

#000121390024041818 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $455.3K $698.4K
YoY Change -62.6% -46.91%
% of Gross Profit
Research & Development $836.2K $396.3K
YoY Change 33.49% -45.29%
% of Gross Profit
Depreciation & Amortization $11.02K $11.01K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $1.374M $27.37K
YoY Change -26.91% -98.68%
Operating Profit -$1.374M -$1.136M
YoY Change -26.91% -45.37%
Interest Expense $751.2K $673.5K
YoY Change 19.04% 7.46%
% of Operating Profit
Other Income/Expense, Net $1.586M -$764.1K
YoY Change -70.29% -109.29%
Pretax Income -$538.9K -$2.577M
YoY Change -118.73% -147.32%
Income Tax
% Of Pretax Income
Net Earnings -$538.9K -$2.577M
YoY Change -118.73% -147.32%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 85.96M shares 85.93M shares
Diluted Shares Outstanding 85.93M shares 85.93M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $612.8K $440.5K
YoY Change -70.01% -87.73%
Cash & Equivalents $612.8K $440.5K
Short-Term Investments
Other Short-Term Assets $112.3K $107.7K
YoY Change -42.65% -48.85%
Inventory
Prepaid Expenses $112.3K $100.7K
Receivables
Other Receivables
Total Short-Term Assets $725.1K $548.2K
YoY Change -67.62% -85.58%
LONG-TERM ASSETS
Property, Plant & Equipment $1.022M $1.033M
YoY Change -4.13% -4.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.116M $1.116M
YoY Change 0.0% 0.0%
Total Long-Term Assets $60.43M $60.51M
YoY Change -1.18% -1.06%
TOTAL ASSETS
Total Short-Term Assets $725.1K $548.2K
Total Long-Term Assets $60.43M $60.51M
Total Assets $61.15M $61.06M
YoY Change -3.52% -6.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.540M $1.670M
YoY Change 44.03% 65.05%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $29.07M $26.82M
YoY Change 20.61% 14.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $30.69M $30.20M
YoY Change 21.4% 18.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.641M $2.640M
YoY Change -58.55% -75.6%
Total Long-Term Liabilities $2.641M $2.640M
YoY Change -58.55% -75.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.69M $30.20M
Total Long-Term Liabilities $2.641M $2.640M
Total Liabilities $33.33M $32.84M
YoY Change 5.3% -9.65%
SHAREHOLDERS EQUITY
Retained Earnings -$36.35M -$35.81M
YoY Change 15.14% 3.96%
Common Stock $8.593K $8.593K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.82M $28.22M
YoY Change
Total Liabilities & Shareholders Equity $61.15M $61.06M
YoY Change -3.52% -6.0%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$538.9K -$2.577M
YoY Change -118.73% -147.32%
Depreciation, Depletion And Amortization $11.02K $11.01K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$1.328M -$610.2K
YoY Change -14.2% -82.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.500M $750.0K
YoY Change -88.89%
NET CHANGE
Cash From Operating Activities -1.328M -$610.2K
Cash From Investing Activities
Cash From Financing Activities 1.500M $750.0K
Net Change In Cash 172.3K $139.8K
YoY Change -111.13% -95.71%
FREE CASH FLOW
Cash From Operating Activities -$1.328M -$610.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Vancouver
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
BC
CY2024Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2024Q1 dei City Area Code
CityAreaCode
(604)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
687-1717
CY2024Q1 dei Security12b Title
Security12bTitle
None
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85959753 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
440517 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300734 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
100677 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
55999 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7028 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7028 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
548222 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
363761 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1033378 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1044392 usd
CY2024Q1 augg Reclamation Bonds
ReclamationBonds
1115813 usd
CY2023Q4 augg Reclamation Bonds
ReclamationBonds
1115813 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
58360123 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
58992286 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
60509314 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
61152491 usd
CY2024Q1 us-gaap Assets
Assets
61057536 usd
CY2023Q4 us-gaap Assets
Assets
61516252 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1669664 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1411439 usd
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1340365 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
692949 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
374259 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
110700 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30201642 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27608967 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2105269 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2971097 usd
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
534401 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
417758 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2639670 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3388855 usd
CY2024Q1 us-gaap Liabilities
Liabilities
32841312 usd
CY2023Q4 us-gaap Liabilities
Liabilities
30997822 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85929753 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85929753 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85929753 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85929753 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
8593 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
8593 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64020617 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63745580 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35812986 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33235743 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28216224 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30518430 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61057536 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
61516252 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
698435 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1315572 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
396258 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
724270 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
29894 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
27907 usd
CY2024Q1 us-gaap Depreciation
Depreciation
11014 usd
CY2023Q1 us-gaap Depreciation
Depreciation
11014 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1135601 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2078763 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1135601 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2078763 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
764059 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8223387 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
673475 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
626715 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4108 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-71951 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2577243 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5445958 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85929753 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84435276 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85929753 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84660278 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
16489511 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
472981 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
7867426 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1668671 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5445958 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28607205 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30518430 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
275037 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2577243 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
28216224 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2577243 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5445958 usd
CY2024Q1 us-gaap Accretion Expense
AccretionExpense
29894 usd
CY2023Q1 us-gaap Accretion Expense
AccretionExpense
27907 usd
CY2024Q1 us-gaap Depreciation
Depreciation
11014 usd
CY2023Q1 us-gaap Depreciation
Depreciation
11014 usd
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
764059 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8223387 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
275037 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
472981 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
44678 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
46587 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-121424 usd
CY2024Q1 augg Increase Decrease Debt Issuance Costs
IncreaseDecreaseDebtIssuanceCosts
-30680 usd
CY2023Q1 augg Increase Decrease Debt Issuance Costs
IncreaseDecreaseDebtIssuanceCosts
-37401 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
258225 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1894673 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
642795 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
589315 usd
CY2024Q1 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
0 usd
CY2023Q1 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-35010 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-610217 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3493657 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
8568651 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
750000 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
701225 usd
CY2024Q1 augg Increase In Surety Bond Collateral
IncreaseInSuretyBondCollateral
0 usd
CY2023Q1 augg Increase In Surety Bond Collateral
IncreaseInSuretyBondCollateral
1115813 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
750000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6751613 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
139783 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3257956 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300734 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
332813 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
440517 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3590769 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q1 augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
632163 usd
CY2023Q1 augg Incurrence Of Asset Retirement Obligation
IncurrenceOfAssetRetirementObligation
0 usd
CY2024Q1 augg Warrant Liability From Units Placement
WarrantLiabilityFromUnitsPlacement
0 usd
CY2023Q1 augg Warrant Liability From Units Placement
WarrantLiabilityFromUnitsPlacement
1668671 usd
CY2024Q1 augg Working Capital Deficiency
WorkingCapitalDeficiency
30000000 usd
CY2024Q1 us-gaap Cash
Cash
440000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Critical Judgements and Estimation Uncertainties</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, and expenses. These estimates and judgements are subject to change based on experience and new information which could result in outcomes that require a material adjustment to the carrying amounts of assets or liabilities affecting future periods. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized prospectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Impairment of mineral properties</i> – Management applies significant judgment in its assessment of mineral properties and whether there are any indications of impairment. The Company considers both internal and external sources of information when making the impairment assessment. External sources of information considered are changes in the Company’s economic, legal and regulatory environment, which it does not control, but affects the recoverability of its mining assets. Internal sources of information the Company considers include the manner in which mining properties are expected to be used and indications of economic performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Share-based compensation</i> – The fair value of share-based compensation is calculated using the Black-Scholes model. The main assumptions used in the model include the estimated life of the option, the expected volatility of the Company’s share price, and the risk-free rate of interest. The resulting value calculated is not necessarily the value that the holder of the option could receive in an arm’s-length transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Warrant liability</i> – The fair value of the warrant liability is calculated using the Black-Scholes model. The main assumptions used in the model include the estimated life of the warrant, the expected volatility of the Company’s share price, and the risk-free rate of interest. The resulting value calculated is not necessarily the value that the holder of the warrant could receive in an arm’s-length transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Asset retirement obligation</i> – Significant judgment is involved in the determination of future reclamation costs, inflation rates, discount rate, and the life of mine. Revisions to these inputs may result in an adjustment to the carrying value of the obligation and the mineral properties involved.</p>
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
3081797 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
2814435 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
29894 usd
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
111548 usd
CY2024Q1 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0 usd
CY2023 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
59285 usd
CY2024Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
-632163 usd
CY2023 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
215099 usd
CY2024Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
374259 usd
CY2023Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
110700 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2105269 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
2971097 usd
CY2024Q1 augg Asset Retirement Obligation Life Of Mine
AssetRetirementObligationLifeOfMine
2031
CY2023 augg Asset Retirement Obligation Life Of Mine
AssetRetirementObligationLifeOfMine
2031
CY2024Q1 augg Asset Retirement Obligation Life Of Mine Reward Project
AssetRetirementObligationLifeOfMineRewardProject
2029
CY2023 augg Asset Retirement Obligation Life Of Mine Reward Project
AssetRetirementObligationLifeOfMineRewardProject
2029
CY2024Q1 augg Asset Retirement Obligation Discount Rate
AssetRetirementObligationDiscountRate
0.115 pure
CY2023 augg Asset Retirement Obligation Discount Rate
AssetRetirementObligationDiscountRate
0.039 pure
CY2024Q1 augg Asset Retirement Obligation Inflation Rateaverage
AssetRetirementObligationInflationRateaverage
0.022 pure
CY2023 augg Asset Retirement Obligation Inflation Rateaverage
AssetRetirementObligationInflationRateaverage
0.022 pure
CY2024Q1 augg Cash Flows Rate
CashFlowsRate
0.115 pure
CY2023Q1 augg Cash Flows Rate
CashFlowsRate
0.036 pure
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2577243 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
5445958 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85929753 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84435276 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
225002 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85929753 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84660278 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2023Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
225002 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
39526615 shares
CY2023Q1 augg Number Of Dilutive And Antidilutive Shares
NumberOfDilutiveAndAntidilutiveShares
39751617 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8167 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4613336 shares
CY2022Q4 augg Mineral Properties And Equipment
MineralPropertiesAndEquipment
60139481 usd
CY2023 augg Mineral Properties And Equipment Total Additions
MineralPropertiesAndEquipmentTotalAdditions
30000 usd
CY2023Q4 augg Mineral Properties And Equipment
MineralPropertiesAndEquipment
60169481 usd
CY2024Q1 augg Total Change In Aro Estimate
TotalChangeInAROEstimate
-632163 usd
CY2024Q1 augg Mineral Properties And Equipment Total Additions
MineralPropertiesAndEquipmentTotalAdditions
0 usd
CY2024Q1 augg Mineral Properties And Equipment
MineralPropertiesAndEquipment
59537318 usd
CY2022Q4 augg Accumulateddepreciation Mineralproperties
AccumulateddepreciationMineralproperties
88746 usd
CY2023 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
44057 usd
CY2023Q4 augg Accumulateddepreciation Mineralproperties
AccumulateddepreciationMineralproperties
132803 usd
CY2024Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
11014 usd
CY2024Q1 augg Accumulateddepreciation Mineralproperties
AccumulateddepreciationMineralproperties
143817 usd
CY2024Q1 augg Net Book Value On Total
NetBookValueOnTotal
59393501 usd
CY2021Q1 augg Shares Outstanding Percentage
SharesOutstandingPercentage
0.10 pure
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
135552 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
472981 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5200002 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y5M12D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
57468 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
190000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.02
CY2023 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Canceled Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCanceledWeightedAverageRemainingContractualTerm2
P0Y
CY2023 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Canceled
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueCanceled
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5010002 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.48
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y5M4D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
196667 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.02
CY2024Q1 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Canceled Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsCanceledWeightedAverageRemainingContractualTerm2
P0Y
CY2024Q1 augg Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Canceled
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueCanceled
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4813335 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.45
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M20D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.45
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y1M17D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8167 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30887574 shares
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1340365 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
692949 usd
CY2023 augg Warrant Liability
WarrantLiability
692949 usd
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
534401 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
417758 usd
CY2022Q3 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
22232561 usd
CY2024Q1 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.03 pure
CY2024Q1 augg Investments An Origination Fee Percentage
InvestmentsAnOriginationFeePercentage
0.005 pure
CY2023Q4 augg Extension Fee
ExtensionFee
33501 usd
CY2024Q1 augg Agreed To Purchase
AgreedToPurchase
22232561 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
525000 usd
CY2024Q1 us-gaap Loan Processing Fee
LoanProcessingFee
25000 usd
CY2024Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
22818853 usd
CY2022Q3 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
22126000 usd
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
106561 usd
CY2023Q4 augg Lender Extension Fee
LenderExtensionFee
33501 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Loan Purchased
FinancingReceivableAllowanceForCreditLossLoanPurchased
500000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
25000 usd
CY2024Q1 augg Extension Fee
ExtensionFee
27791 usd
CY2024Q1 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.03 pure
CY2024Q1 us-gaap Investment Maturity Date
InvestmentMaturityDate
2024-06-30
CY2024Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
250000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
12500 usd
CY2024Q1 us-gaap Short Term Debt Percentage Bearing Variable Interest Rate
ShortTermDebtPercentageBearingVariableInterestRate
0.14 pure
CY2024Q1 us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
0.62
CY2024Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
97370 usd
CY2024Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
74556 usd
CY2023Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
153306 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
23240 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
27228 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
27374 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
50089 usd
CY2024Q1 augg Office Expense Net
OfficeExpenseNet
125170 usd
CY2023Q1 augg Office Expense Net
OfficeExpenseNet
230623 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4813335 shares
CY2024Q1 augg Percentage Of Consulting Arrangement
PercentageOfConsultingArrangement
1 pure
CY2024Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
91876 usd
CY2023Q1 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
91876 usd
CY2024Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
583324 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
520825 usd
CY2017Q3 augg Number Of Patented Mining
NumberOfPatentedMining
24 pure
CY2017Q3 augg Undivided Interest Percentage
UndividedInterestPercentage
1 pure
CY2024Q1 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
500000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
132000 usd
CY2014Q4 us-gaap Area Of Land
AreaOfLand
156 acre
CY2024Q1 augg Property Interset Rate
PropertyIntersetRate
1 pure
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
190000 usd
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P10Y
CY2023Q1 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
25000 cad
CY2021Q4 us-gaap Cash
Cash
50000 cad
CY2023Q1 us-gaap Cash
Cash
78750 cad
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.02 pure
CY2023Q1 augg Percentage Of Option Purchase
PercentageOfOptionPurchase
0.005 pure
CY2023Q1 us-gaap Purchase Obligation
PurchaseObligation
500000 cad
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
396258 usd
CY2024Q1 augg Reclamation Bonds
ReclamationBonds
1115813 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
58360123 usd
CY2023 us-gaap Exploration Expense
ExplorationExpense
2686656 usd
CY2023Q4 augg Reclamation Bonds
ReclamationBonds
1115813 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
58992286 usd
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001448597
CY2024Q1 dei No Trading Symbol Flag
NoTradingSymbolFlag
true

Files In Submission

Name View Source Status
augg-20240331_cal.xml Edgar Link unprocessable
0001213900-24-041818-index-headers.html Edgar Link pending
0001213900-24-041818-index.html Edgar Link pending
0001213900-24-041818.txt Edgar Link pending
0001213900-24-041818-xbrl.zip Edgar Link pending
augg-20240331.xsd Edgar Link pending
ea0205378-10q_augusta.htm Edgar Link pending
ea020537801ex31-1_augusta.htm Edgar Link pending
ea020537801ex31-2_augusta.htm Edgar Link pending
ea020537801ex32-1_augusta.htm Edgar Link pending
ea020537801ex32-2_augusta.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
augg-20240331_def.xml Edgar Link unprocessable
augg-20240331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0205378-10q_augusta_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
augg-20240331_pre.xml Edgar Link unprocessable